Low-Dose Cytosine Arabinoside in Patients with Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

The results of treatment with low dose cytosine arabinoside (LDARA-C) in 131 AML patients ineligible for standard regimens were analyzed retrospectively. Eighty-seven were previously untreated, 25 were refractory to conventional chemotherapy and 19 were relapsed patients. The median age was 66 years...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 1995, Vol.18 (5-6), p.465-469
Hauptverfasser:	Pascarella, A., Marrani, C., Leoni, F., Ciolli, S., Nozzoli, C., Caporale, R., Salti, F., Ferrini, P. Rossi
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Aged AML chemotherapy Cytarabine - administration & dosage Dose-Response Relationship, Drug Female Humans LDARA-C Leukemia, Myeloid - drug therapy Male Middle Aged prognosis Retrospective Studies Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!